AddLife AB (publ) (LON: 0REZ)

Market Cap	1.30B
Revenue (ttm)	736.51M
Net Income (ttm)	8.61M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	150.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 10, 2024

Volume	242
Average Volume	1,401
Open	145.30
Previous Close	145.84
Day's Range	144.80 - 145.70
52-Week Range	54.85 - 145.70
Beta	1.35
RSI	62.08
Earnings Date	Feb 5, 2025

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,301
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2023, AddLife AB's revenue was 9.69 billion, an increase of 6.62% compared to the previous year's 9.08 billion. Earnings were 190.00 million, a decrease of -60.42%.

Financial numbers in SEK